Entero Therapeutics Income Tax

As of the most recent data (June 2026), ENTO shows a income tax of $-13M. That compares with $11M in the prior-year period — down 221.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENTO's income tax is now $-13M (was $11M) — a 221.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Entero Therapeutics is outperforming or lagging.

Tracking ENTO's income tax over time shows whether Entero Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $-13M That compares with $11M in the prior-year period — down 221.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this income tax page, Stockcircle has Entero Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect income tax (currently $-13M) with ownership activity and broader fundamentals.